Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 0.16 ▲ 0.01 (4.80%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Onconova Therapeutics Inc | ONTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.0095 | -5.8% | 0.1543 | 0.18 | 0.1443 | 0.176 | 0.1638 | 19:57:53 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.1532 | 0.1617 | 0.0085 | 5.26% | 1 | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,017 | 9,927,255 | $ 0.1633566 | $ 1,621,683 | 504,232 | 0.1443 - 5.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:56 | formt | 6,400 | $ 0.1617 | USD |
Onconova Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 925.57k | 6.00M | $ -20.57M | -7.93 | - | 4.94M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 3.00 | 17.60% |
Onconova Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.315 | 0.77 | 0.1443 | 0.1680244 | 7,918,326 | -0.1607 | -51.02% |
| 1 Month | 0.774 | 0.786883 | 0.1443 | 0.2077998 | 2,259,335 | -0.6197 | -80.06% |
| 3 Months | 2.24 | 2.84 | 0.1443 | 0.5149259 | 1,078,740 | -2.09 | -93.11% |
| 6 Months | 3.57 | 4.00 | 0.1443 | 0.5782986 | 520,364 | -3.42 | -95.68% |
| 1 Year | 3.57 | 5.25 | 0.1443 | 0.9964169 | 320,048 | -3.42 | -95.68% |
| 3 Years | 48.30 | 58.20 | 0.1443 | 9.89 | 481,009 | -48.15 | -99.68% |
| 5 Years | 73.20 | 122.55 | 0.1443 | 13.72 | 352,816 | -73.05 | -99.79% |
Onconova Therapeutics Description
| Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the US. It focuses on discovering and developing novel small molecule product candidates primarily to treat cancer. The company has created a library of targeted agents designed to work against cellular pathways important to cancer cells. Its product candidates are Single-agent IV rigosertib, Oral rigosertib + azacitidine, IV Briciclib, Recilisib, and ON 123300. The key product candidate Rigosertib is a small molecule which blocks cellular signaling by targeting RAS effector pathways. |
